Detalhe da pesquisa
1.
A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination.
Epilepsia
; 64(2): 374-385, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268811
2.
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program.
Epilepsia
; 63(1): 139-149, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813673
3.
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Epilepsia
; 63(8): 2024-2036, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582748
4.
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
Epilepsia
; 62(12): 3016-3028, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633074
5.
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Epilepsia
; 62(12): 3005-3015, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633084
6.
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
Epilepsia
; 62(6): 1442-1450, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942315
7.
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
Epilepsia
; 62(10): 2485-2495, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418086
8.
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
Epilepsia
; 61(4): 636-646, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221987
9.
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Epilepsia
; 60(12): 2437-2447, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755090
10.
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Epilepsy Behav
; 82: 119-127, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29604484
11.
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Epilepsy Behav
; 72: 127-134, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575761
12.
Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
Epilepsia
; 57(7): 1130-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221208
13.
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
Epilepsia
; 56(6): 915-23, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25982590
14.
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Epilepsia
; 56(6): 906-14, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912051
15.
Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Epilepsy Behav
; 52(Pt A): 119-27, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414341
16.
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Epilepsia
; 55(1): 57-66, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24446953
17.
Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
Epilepsia
; 55(8): 1220-8, 2014 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962242
18.
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Int J Clin Pharmacol Ther
; 52(6): 509-18, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24755135
19.
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.
J Neurol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730096
20.
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.
Epilepsia
; 54(8): 1437-43, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692516